drugset / Trial / NCT00925704

The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers

NCT00925704

Phase 1 Completed 41 enrolled Shire
RandomizedCrossoverOpen-labelOther

Summary

To assess the effects of lanthanum carbonate (FOSRENOL) or sevelamer carbonate (RENVELA) on the pharmacokinetics of oral calcitriol (ROCALTROL)

Timeline

Start
2009-06-01
Primary completion
2009-07-31
Completion
2009-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcitriol Small molecule 1 ug Oral
Subject Lanthanum Carbonate Other / unclassified 1000 mg
Subject sevelamer Other / unclassified 2400 mg

Indications

No indication recorded.